Throughout the year, The American Journal of Managed Care® (AJMC®) offered a number of video programs, including Peer Exchange discussions and interviews, on a range of topics. Here are the most-watched videos published by AJMC® in 2018.
Throughout the year, The American Journal of Managed Care® (AJMC®) offered a number of video programs, including Peer Exchange discussions and interviews, on a range of topics.
Here are the most-watched videos published by AJMC® in 2018.
5. The Importance of Adding the Diabetes Prevention Program to Medicare
In April, Medicare took the historic step of launching the Diabetes Prevention Program (DPP), an evidence-based program that has been shown to reduce the incidence of people with prediabetes progressing to type 2 diabetes. Before DPP launched, Brenda Schmidt, chief executive officer of Solera Health, an integrator that serves as the “back office” for both community-based and digital providers of the DPP, discussed the historic importance of adding the DPP to Medicare, key features of the final rule, and what health plans needed to do to be ready to meet client needs starting in April.
Watch the video with Brenda Schmidt.
4. Addressing Unmet Needs in Multiple Myeloma
As part of the Insights series, Current Treatment Regimens for Multiple Myeloma, Amrita Krishnan, MD, FACP, of City of Hope Cancer Center, outlined the greatest unmet needs in the treatment of multiple myeloma, including patients who have central nervous system relapse, and discussed the efforts being undertaken to address them.
Watch the video with Amrita Krishnan, MD, FACP.
3. Dr Adam Brufsky: Choosing a Therapy for Breast Cancer Patients
There are a number of treatment choices available to treat patients with breast cancer, and diagnostic tests can assist in the decision-making process. In this interview from February, Adam M. Brufsky, MD, PhD, codirector of the Comprehensive Breast Cancer Center at University of Pittsburgh, explains how to decide between chemotherapy, endocrine therapy, or targeted therapy for patients and what role diagnostic tests can play.
Watch the interview with Adam Brufsky, MD, PhD.
2. Today's HIV Treatment Challenges
At the beginning of 2018, AJMC® published a Peer Exchange with a panel of experts in infectious disease and managed care who discussed today’s management of HIV, including the need for individualized care and the role of newer treatment options.
In this specific segment, Peter L. Salgo, MD; Elly Fatehi, PharmD, MPH; Michael Sension, MD; and Jeffrey Dunn, PharmD, offered their perspectives on the current treatment challenges with HIV infection, including medication adherence.
Watch the Peer Exchange segment.
Or, watch the entire Peer Exchange, Special Considerations in HIV Management.
1. Rick Doubleday Outlines the Partnership Between Dexcom and Fitbit
Dexcom develops, manufactures, and distributes continuous glucose monitoring systems for diabetes management, and in late 2017, it partnered with Fitbit. Rick Doubleday, the executive vice president and chief commercial officer at Dexcom, sat in AJMC®’s studio to discuss the partnership with Fitbit and what patients with type 1 and type 2 diabetes would get out of it.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More